PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
Gilching (pta019/02.09.2022/11:05) – Announcement
Gilching (pta019/02.09.2022/11:05) – Announcement
Gilching (pta034/23.08.2022/16:30) – The supervisory board of Dr. Hönle AG has decided to fill the position of CEO, which was newly created in the course of the restructuring of the Management Board, with Management Board member Norbert Haimerl. Mr. Haimerl will assume the position of CEO from September 1, 2022.
Gilching (pta009/05.08.2022/08:00) – Sales revenues generated by the Hönle Group rose by 12% to T€ 95,141 in the first nine months of financial year 2021/2022 compared with the prior-year period.
Gilching (pta042/29.07.2022/14:20) – Earnings in the third quarter were worse than planned. The situation on procurement markets and the increase in energy prices burden on quarterly earnings heavily. In addition, one-time effects affected the result. These are largely related to the personnel changes implemented at the management level of Dr. Hönle AG.
Gilching (pta028/22.07.2022/14:55) – Business development in the third quarter and especially in June 2022 was significantly worse than planned. The situation on procurement markets and the sharp increase in energy prices temporarily burden heavily on the Hönle Group’s earnings. In addition, one-time effects affect the result. These are largely related to the personnel changes implemented at the management level of Dr. Hönle AG.
Gilching (pta026/16.05.2022/11:45) – The supervisory board of Dr. Hönle AG has decided to restructure the Management Board of Dr. Hönle AG.
Gilching (pta006/12.05.2022/08:00) – The economic recovery impacted positively on the Hönle Group’s course of business. Both incoming orders and order backlog were clearly above the prior year’s level. An even higher rise in revenue failed to realise due to long delivery times concerning electrical and electronic components, in particular. In all, sales revenues earned by the Hönle Group in the first six months of financial year 2021/2022 came to T€ 66,240, which translates into a 15.0% increase versus the prior year’s value.
Gilching (pta043/11.05.2022/19:30) – Dr. Hönle AG announces that the following financial reports shall be disclosed:
Gilching (pta104/31.03.2022/15:35) – Announcement
Gilching (pta031/23.03.2022/14:30) – Release of Voting Rights Announcement